CClinicalTrials.gg
CompletedNCT03036982Updated Mar 27, 2018

Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma

An observational study in Asthma, sponsored by Boston Children's Hospital. Completed at 1 site in United States. Open to participants aged 4 Years to 21 Years. Per ClinicalTrials.gov, last updated 2018-03-27.

Sponsored by Boston Children's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
221
Ages
4 Years to 21 Years
Sex
All
01

Study summary

This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma Control Test (cACT) for mobile devices improves rate of completion and improves control of asthma in children and adolescents

Read the detailed description

Asthma is the most prevalent chronic disease of childhood with an overall prevalence of 10%. While effective therapies exist to control symptoms and prevent exacerbations, many asthma patients experience significant morbidity including limitations on daily activities as well as asthma exacerbations that lead to missed school (and work for care givers) and necessitate emergency department visits and hospitalizations. Among children from lower socioeconomic statues and in black and Hispanic families, asthma incidence and severity are even greater. Reasons for this disparity included decreased access to effective asthma care, increased exposure to tobacco smoke and environmental allergens, and underutilization of controller medicines. These groups have significantly increased resource utilization due to emergency department visits and hospitalizations. Optimal care for asthma patients, especially those with at highest risk, will therefore require new strategies for evaluating ongoing control and providing direct feedback to patients.

We propose to transform the way asthma care is provided through the use of an innovative patient centered technology -Trivox Asthma - to improve quality of care and outcomes for asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to facilitate closer monitoring of patients with asthma through the existing web platform and a new mobile interface. This will allow asthma patients, their parents and school nurses to remotely input data on asthma control through smartphones and/or tablets. We will use the ACT+, an expansion of a validated measure currently utilized in both primary care and specialty clinics, to measure both asthma control and risk.

Effectiveness of this intervention will be measured by examining resource utilization and ongoing asthma control.

02

Conditions studied

  • Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 221 is above the median of 150 across 970 observational studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with asthma seen in one of the clinics caring for patients with asthma at Boston Children's Hospital Age 4-21

Inclusion criteria

  • Diagnosis of asthma
  • Cared for at Boston Children's Hospital (Primary or secondary care)

Exclusion criteria

Exclusion Criteria:

  • Age \<4 or >21
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
221 participants (actual)
Patient registry
No

Groups and cohorts

  • Use of Mobile ACT

    Will answer ACT (or cACT) and other asthma questions using mobile app

06

What researchers measure

Primary outcomes

  1. Well-controlled asthma

    Percent of ACT scores with value of 20 or greater

    Time frame: Each month for one calendar year

Secondary outcomes

  1. Asthma Emergency Department visits and hospitalizations

    Asked every 3 months

    Time frame: Total Emergency Department Visits and hospitalizations with asthma as one of top diagnosis in one year

07

Study locations

1 site
  • Boston Childrens Hospital
    Boston, Massachusetts 02115, United States
08

References and documents

Individual participant data

Plan to share: Yes — Will make deidentified data available for other researchers

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03036982
Lead sponsor
Boston Children's Hospital
Responsible party
Andrew MacGinnitie (Associate Clinical Director, Division of Immunology, Boston Children's Hospital) — Principal investigator
First posted
Jan 31, 2017
Start date
Jan 1, 2016
Primary completion
Apr 30, 2017
Completion
Dec 31, 2017
Last update
Mar 27, 2018

Study contacts

Andrew MacGinnitie, MD PhD
principal investigator · Boston Children's Hosptial

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion